Evidence map›Paper›PMID 35482791›Full record

SynthesisPloS one2022

Epidemiological characteristics, routine laboratory diagnosis, clinical signs and risk factors for hand, -foot -and -mouth disease: A systematic review and meta-analysis.

Zhijie Yi, Shujun Pei, Wenshuai Suo, Xiaoyang Wang, Zengyuan Huang, Aihua Yi, Bohao Wang, Zhiquan He, Ruolin Wang, Yi Li and 2 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Epidemiologic and clinical updates on viral infections in Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhijie YiCollege of Public Health, Zhengzhou University, Zhengzhou, China.
Shujun PeiCollege of Public Health, Xinxiang Medical University, Xinxiang, China.
Wenshuai SuoCollege of Public Health, Zhengzhou University, Zhengzhou, China.
Xiaoyang WangCollege of Public Health, Zhengzhou University, Zhengzhou, China.
Zengyuan HuangFifth Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, China.
Aihua YiFirst Affiliated Hospital of Shaoyang University, Shaoyang, China.
Bohao WangQuality Control Department of Henan Children's Hospital, Zhengzhou, China.
Zhiquan HeHenan Province Center for Disease Control and Prevention, Zhengzhou, China.
Ruolin WangHenan Province Center for Disease Control and Prevention, Zhengzhou, China.
Yi LiHenan Province Center for Disease Control and Prevention, Zhengzhou, China.
Wei FanHenan Province Center for Disease Control and Prevention, Zhengzhou, China.
Xueyong HuangCollege of Public Health, Zhengzhou University, Zhengzhou, China.ORCID 0000-0001-8995-9274

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFor the past few years, only a few monovalent EV71 vaccines have been developed, while other enterovirus vaccines are in short supply. We conducted a quantitative meta-analysis to explore the epidemiological characteristics, routine laboratory diagnosis, clinical signs and risk factors for hand, foot and mouth disease (HFMD).

methodsPubMed, Embase and the Web of Science were searched for eligible reports published before April 16, 2021, with no publication time or language restrictions. The primary outcome was the odds ratio of the epidemiological characteristics, routine laboratory diagnosis, and clinical signs associated with HFMD severity and death.

resultsAfter screening 10522 records, we included 32 articles comprising 781903 cases of hand, foot and mouth disease. Patients with severe illness developed some clinical signs (hypersomnia (OR = 21.97, 95% CI: 4.13 to 116.74), convulsion (OR = 16.18, 95% CI: 5.30 to 49.39), limb shaking (OR = 47.96, 95% CI: 15.17 to 151.67), and breathlessness (OR = 7.48, 95% CI: 1.90 to 29.40)) and had some changes in laboratory parameters (interleukin-6 levels standardized mean difference (SMD) = 1.57, 95%CI: 0.55 to 2.60), an increased neutrophils ratio (SMD = 0.55, 95%CI: 0.17 to 0.93), cluster of differentiation 4 (CD4+) (SMD = -1.38, 95%CI: -2.33 to -0.43) and a reduced lymphocytes ratio (SMD = -0.48, 95%CI: -0.93 to -0.33)) compared with patients with mild illness. The risk factors for death included cyanosis (OR = 5.82, 95% CI: 2.29 to 14.81), a fast heart rate (OR = 3.22, 95% CI: 1.65 to 6.30), vomiting (OR = 2.70, 95% CI: 1.33 to 5.49) and an increased WBC count (SMD = 0.60, 95% CI: 0.27 to 0.93).

conclusionsChina has the highest incidence of HFMD. Our meta-analyses revealed important risk factors that are associated with the severity and mortality of HFMD.

Indexed as

Enterovirus A, HumanHand, Foot and Mouth DiseaseMouth DiseasesBlood Coagulation TestsHumansRisk Factors

Identifiers

PMID35482791
PMCPMC9049560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.